{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T13:13:22Z","timestamp":1777727602681,"version":"3.51.4"},"reference-count":25,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014383","name":"Italfarmaco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Int Med Res"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Recurrent bacterial vaginosis (RBV) after antibiotic treatment has relapse rates of 35% within 3 months and 60% within 12 months. A medical device containing polycarbophil, lauryl glucoside, and glycerides (PLGG) inhibits bacterial growth and has mucoadhesive properties. This study examined the efficacy of the device in women with RBV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This post-market clinical follow-up study comprised two phases. The first phase was an interventional, open-label, non-controlled, multicenter study enrolling 56 women. The second phase was an observational 10-month follow-up without treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After three cycles of PLGG treatment, recurrence was identified in 8 of 54 evaluable patients (14.81%). A positive effect on lactobacilli in the vaginal secretions was observed in 26 of 39 patients (66.67%). Among 35 patients observed after stopping PLGG treatment, one case of RBV (2.86%) was observed after 4 months, and an additional six cases (17.14%) were observed after 10\u2009\u00b1\u20092 months. Therefore, no recurrence was evidenced in 12 subjects (34.28%) at the end of the study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The use of PLGG vaginal ovules in the treatment of BV reduces the rate of recurrence and apparently produces a positive effect on the vaginal microbiota.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/03000605241239021","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T06:16:56Z","timestamp":1715321816000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["POLARIS: efficacy and safety of a vaginal medical device in recurrent bacterial vaginosis\u2014a multicenter, open-label, non-controlled, study with 10 months of follow-up"],"prefix":"10.1177","volume":"52","author":[{"given":"Filippo","family":"Murina","sequence":"first","affiliation":[{"name":"Lower Genital Tract Disease Unit, V. Buzzi Hospital-University of Milan, Italy"},{"name":"Postgraduate School of Gynecology and Obstetrics, University of Milan, Milano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Inghirami","sequence":"additional","affiliation":[{"name":"AIED Centre, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marius","family":"Biri\u0219","sequence":"additional","affiliation":[{"name":"Clinica Medical\u0103 Biri\u0219 Marius, Timi\u0219oara, Rom\u00e2nia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"S\u00eerbu","sequence":"additional","affiliation":[{"name":"Clinica Medical\u0103 Dr. S\u00eerbu Daniela, Timi\u0219oara, Rom\u00e2nia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9931-6432","authenticated-orcid":false,"given":"Dionisio Franco","family":"Barattini","sequence":"additional","affiliation":[{"name":"Opera CRO, a TIGERMED Group company, Timi\u0219oara, Rom\u00e2nia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca Ivan","family":"Ardolino","sequence":"additional","affiliation":[{"name":"Italfarmaco SpA, Cinisello Balsamo \u2013 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Mangrella","sequence":"additional","affiliation":[{"name":"Italfarmaco SpA, Cinisello Balsamo \u2013 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Casolati","sequence":"additional","affiliation":[{"name":"Private Practice of Obstetrics and Gynecology, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serban Marius","family":"Ro\u0219u","sequence":"additional","affiliation":[{"name":"University of Medicine and Pharmacy Victor Babe\u0219, Timi\u0219oara, Rom\u00e2nia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciprian","family":"Cri\u0219an","sequence":"additional","affiliation":[{"name":"Clinica Medical\u0103 Dr. Cri\u0219an Ciprian, Timi\u0219oara, Rom\u00e2nia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2024,5,10]]},"reference":[{"key":"bibr1-03000605241239021","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.02007"},{"key":"bibr2-03000605241239021","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.672429"},{"key":"bibr3-03000605241239021","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2011.03.016"},{"key":"bibr4-03000605241239021","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu966"},{"key":"bibr5-03000605241239021","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2004.02.015"},{"key":"bibr6-03000605241239021","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-009-0068-5"},{"key":"bibr7-03000605241239021","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.30.4.870-877.1992"},{"key":"bibr8-03000605241239021","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2002.002733"},{"key":"bibr9-03000605241239021","doi-asserted-by":"publisher","DOI":"10.1086\/503780"},{"key":"bibr10-03000605241239021","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000516"},{"key":"bibr11-03000605241239021","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.6304"},{"key":"bibr12-03000605241239021","doi-asserted-by":"publisher","DOI":"10.1111\/j.1542-2011.2012.00179.x"},{"key":"bibr13-03000605241239021","doi-asserted-by":"publisher","DOI":"10.1016\/j.curtheres.2016.07.002"},{"key":"bibr14-03000605241239021","unstructured":"Ardolino LI, Rimbault F, Bretelle F. Une nouvelle approche dans la pr\u00e9vention des r\u00e9cidives de vaginose bact\u00e9rienne.\n                      Revue Genesis\n                      https:\/\/www.revuegenesis.fr\/une-nouvelle-approche-dans-la-prevention-des-recidives-de-vaginose-bacterienne\/ (2020, accessed 23 June 2023)."},{"key":"bibr15-03000605241239021","doi-asserted-by":"publisher","DOI":"10.2196\/42787"},{"key":"bibr16-03000605241239021","doi-asserted-by":"publisher","DOI":"10.23736\/S0026-4784.20.04661-4"},{"key":"bibr17-03000605241239021","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.11.008"},{"key":"bibr18-03000605241239021","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(83)91112-9"},{"key":"bibr19-03000605241239021","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration, CDER, CBER. Bacterial Vaginosis: Developing Drugs for Treatment Guidance for Industry. August 2019. https:\/\/www.fda.gov\/media\/129530\/download."},{"key":"bibr20-03000605241239021","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-09-308858"},{"key":"bibr21-03000605241239021","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2007.01.002"},{"key":"bibr22-03000605241239021","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-015-2490-y"},{"key":"bibr23-03000605241239021","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2019.12.035"},{"key":"bibr24-03000605241239021","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.453654"},{"key":"bibr25-03000605241239021","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2005.11.041"}],"container-title":["Journal of International Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03000605241239021","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/03000605241239021","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03000605241239021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:49:52Z","timestamp":1777459792000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/03000605241239021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["10.1177\/03000605241239021"],"URL":"https:\/\/doi.org\/10.1177\/03000605241239021","relation":{},"ISSN":["0300-0605","1473-2300"],"issn-type":[{"value":"0300-0605","type":"print"},{"value":"1473-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5]]},"article-number":"03000605241239021"}}